Vitalhub (TSE:VHI) PT Set at C$14.00 by Scotiabank

Scotiabank set a C$14.00 price objective on Vitalhub (TSE:VHI) in a research report report published on Thursday morning, Marketbeat Ratings reports. The brokerage currently has an outperform rating on the stock.

Several other equities research analysts also recently weighed in on the stock. TD Securities raised shares of Vitalhub to a “strong-buy” rating in a research report on Monday, November 25th. Canaccord Genuity Group lifted their target price on Vitalhub from C$12.00 to C$12.50 and gave the stock a “buy” rating in a report on Thursday, January 16th. Finally, Cormark upped their price target on Vitalhub from C$9.50 to C$10.50 and gave the company a “buy” rating in a report on Wednesday, October 2nd. Five equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and an average price target of C$10.71.

Vitalhub Price Performance

VHI opened at C$11.40 on Thursday. The firm has a market cap of C$579.69 million, a PE ratio of 103.64, a P/E/G ratio of 1.18 and a beta of 1.26. The stock has a 50-day moving average price of C$11.30 and a 200-day moving average price of C$9.71. Vitalhub has a 1 year low of C$4.36 and a 1 year high of C$12.09.

Vitalhub Company Profile

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.